Please login to the form below

Eoin McAtamney announced as Managing Director of Ashfield Ireland

Ashfield Ireland is delighted to welcome Eoin McAtamney as Managing Director.

Eoin joins Ashfield from Fresenius Kabi in Ireland where he was National Sales Manager. Prior to this, Eoin was Business Unit Director (UK and Ireland) with Pharmed Group, where he managed the Pharmaceutical & OTC division in Ireland and led the successful entry and development of the business into the UK market.

Previously Eoin has gained sales experience in both the pharma and CSO environments. Eoin holds a BA Hons Business Administration, an MBA degree and diplomas in digital marketing and health economics. Eoin is also currently President of the Pharmaceutical Managers Institute (PMI) in Ireland.

Commenting on his appointment, Eoin said: “I am thrilled to have the opportunity to join a company as exciting and innovative as Ashfield. Ashfield has built up a strong reputation in the market, characterised by the quality of both the people and the service it provides.

With experience managing commercial and clinical teams in a number of different environments, I understand the challenges in ensuring the patient experiences the best possible outcomes, as well as the operational sensitivities in the current market.

I’m really looking forward to working with the team in Ireland to grow our existing business, and working in partnership with our clients to further develop innovative, patient-centric services.”

Nigel Mansford, Regional President Ashfield Commercial and Clinical EUCAN, said:  “Ashfield Ireland has established a market leadership position as a result of the highly-skilled, bespoke teams it provides and its continued commitment to quality and results. Eoin has a leadership style and customer focus which makes him a great fit for Ashfield and I look forward to seeing the impact he will have on the Irish business.

Eoin will also bring his experience and ideas to the EUCAN management team, contributing to the direction and growth of Ashfield as an international provider of outsourced healthcare services.”

If you would like to understand more about Ashfield Ireland or get in touch with the team, please click here.

13th October 2017



Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

Ashfield wins Best Newcomer at the Pf Awards 2018
We are thrilled to announce that Zuchaela Smylie, from Ashfield, won Best Newcomer at the 2018 Pf Awards, the largest pharmaceutical sales awards in the UK. The awards ceremony took place on Thursday, 9 March at The Lancaster Hotel in London.
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield to present at the Orphan Drugs for Rare Diseases Summit
Ashfield has a breadth of experience with orphan drugs and we are passionate about helping to improve the lives of people living with rare diseases. We are delighted to be sponsoring and presenting at the ‘Orphan Drugs for Rare Diseases’ event 22-23 March in Berlin.
Addressing the biggest challenges for rare disease communities
Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.
Humanise is our strategic approach to healthcare communications. It’s based on the need to understand. It looks at the emotions that make us human. It examines the feelings we have as individuals. It defines the behaviours we show as people.
Ashfield launches new commercial model to improve ROI
Ashfield, part of UDG Healthcare, a global leader in providing outsourced healthcare services, has announced the launch of a pioneering new commercial model called The Ashfield Solution.